From $3.5 billion to $76 million: what went wrong at one of Israel’s most promising medtech firms?
Israeli digital X-ray developer Nanox was once seen as medical imaging’s next big thing; its latest reports, with a going concern warning and withdrawn revenue forecast, erased nearly all its value, leaving investors facing a bet-or-bail dilemma